Northern Trust’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $62M | Buy |
587,968
+12,850
| +2% | +$1.14M | 0.01% | 986 |
|
|
2025
Q4 | $50.2M | Sell |
575,118
-28,104
| -5% | -$2.3M | 0.01% | 1102 |
|
|
2025
Q3 | $40.1M | Sell |
603,222
-11,844
| -2% | -$673K | 0.01% | 1270 |
|
|
2025
Q2 | $34M | Sell |
615,066
-24,441
| -4% | -$1.17M | ﹤0.01% | 1324 |
|
|
2025
Q1 | $30.9M | Buy |
639,507
+10,927
| +2% | +$458K | ﹤0.01% | 1368 |
|
|
2024
Q4 | $24.3M | Buy |
628,580
+48,491
| +8% | +$2.11M | ﹤0.01% | 1576 |
|
|
2024
Q3 | $26.1M | Buy |
580,089
+71,630
| +14% | +$2.89M | ﹤0.01% | 1459 |
|
|
2024
Q2 | $17.6M | Sell |
508,459
-30,536
| -6% | -$894K | ﹤0.01% | 1633 |
|
|
2024
Q1 | $15.6M | Sell |
538,995
-11,144
| -2% | -$303K | ﹤0.01% | 1764 |
|
|
2023
Q4 | $12.6M | Sell |
550,139
-12,549
| -2% | -$220K | ﹤0.01% | 1913 |
|
|
2023
Q3 | $9.39M | Buy |
562,688
+24,563
| +5% | +$477K | ﹤0.01% | 2052 |
|
|
2023
Q2 | $14.9M | Buy |
538,125
+115,489
| +27% | +$2.89M | ﹤0.01% | 1785 |
|
|
2023
Q1 | $9.72M | Buy |
422,636
+4,029
| +1% | +$67.7K | ﹤0.01% | 2036 |
|
|
2022
Q4 | $4.57M | Buy |
418,607
+824
| +0.2% | +$6.95K | ﹤0.01% | 2541 |
|
|
2022
Q3 | $3.52M | Sell |
417,783
-5,671
| -1% | -$53.7K | ﹤0.01% | 2702 |
|
|
2022
Q2 | $3.35M | Sell |
423,454
-11,624
| -3% | -$141K | ﹤0.01% | 2763 |
|
|
2022
Q1 | $10.3M | Sell |
435,078
-20,333
| -4% | -$573K | ﹤0.01% | 2128 |
|
|
2021
Q4 | $15.6M | Sell |
455,411
-1,566
| -0.3% | -$49.5K | ﹤0.01% | 1951 |
|
|
2021
Q3 | $8.1M | Buy |
456,977
+12,392
| +3% | +$528K | ﹤0.01% | 2435 |
|
|
2021
Q2 | $20M | Buy |
444,585
+29,072
| +7% | +$960K | ﹤0.01% | 1881 |
|
|
2021
Q1 | $10.8M | Buy |
415,513
+11,796
| +3% | +$299K | ﹤0.01% | 2241 |
|
|
2020
Q4 | $8.14M | Buy |
403,717
+19,200
| +5% | +$413K | ﹤0.01% | 2384 |
|
|
2020
Q3 | $7.52M | Buy |
384,517
+58,716
| +18% | +$1.1M | ﹤0.01% | 2275 |
|
|
2020
Q2 | $5.75M | Buy |
325,801
+69,821
| +27% | +$876K | ﹤0.01% | 2428 |
|
|
2020
Q1 | $1.81M | Buy |
255,980
+10,304
| +4% | +$77.2K | ﹤0.01% | 2913 |
|
|
2019
Q4 | $1.73M | Sell |
245,676
-933
| -0.4% | -$9.27K | ﹤0.01% | 3204 |
|
|
2019
Q3 | $2.96M | Buy |
246,609
+176,269
| +251% | +$2.22M | ﹤0.01% | 2866 |
|
|
2019
Q2 | $851K | Buy |
70,340
+31,477
| +81% | +$348K | ﹤0.01% | 3407 |
|
|
2019
Q1 | $489K | Buy |
38,863
+4,239
| +12% | +$37.4K | ﹤0.01% | 3545 |
|
|
2018
Q4 | $234K | Buy |
34,624
+5,084
| +17% | +$40.3K | ﹤0.01% | 3758 |
|
|
2018
Q3 | $304K | Sell |
29,540
-552
| -2% | -$4.75K | ﹤0.01% | 3759 |
|
|
2018
Q2 | $202K | Sell |
30,092
-97,016
| -76% | -$745K | ﹤0.01% | 3852 |
|
|
2018
Q1 | $1.09M | Sell |
127,108
-180
| -0.1% | -$3.39K | ﹤0.01% | 3355 |
|
|
2017
Q4 | $2.65M | Buy |
127,288
+29,676
| +30% | +$526K | ﹤0.01% | 2983 |
|
|
2017
Q3 | $1.73M | Sell |
97,612
-1,213
| -1% | -$16.8K | ﹤0.01% | 3258 |
|
|
2017
Q2 | $1.12M | Buy |
98,825
+19,159
| +24% | +$205K | ﹤0.01% | 3413 |
|
|
2017
Q1 | $1.02M | Sell |
79,666
-2,514
| -3% | -$40.5K | ﹤0.01% | 3344 |
|
|
2016
Q4 | $1.81M | Buy |
82,180
+62,043
| +308% | +$1.38M | ﹤0.01% | 3146 |
|
|
2016
Q3 | $425K | Buy |
+20,137
| New | +$275K | ﹤0.01% | 3551 |
|
Other funds holding PTGX
FCM
RI
VPM
VCM
JJ